The startup is developing a handheld device that measures insulin resistance using non-invasive biosensor technology. This device provides individuals with real-time insights into their metabolic health, enabling better management of conditions like prediabetes and type 2 diabetes.
Funding
Funding not disclosed
Founders
Product
Problem
Current methods for assessing insulin resistance are often invasive, requiring blood draws and laboratory analysis, which can be inconvenient and time-consuming for individuals seeking to understand their metabolic health. This lack of accessible and real-time information hinders proactive management of prediabetes and type 2 diabetes.
Solution
The startup is developing a portable, non-invasive device that measures insulin resistance using advanced biosensor technology. This handheld device provides individuals with real-time feedback on their metabolic status, empowering them to make informed lifestyle choices and better manage their health. By eliminating the need for blood samples and lab visits, the device offers a convenient and accessible way to monitor insulin sensitivity and track the effectiveness of interventions. The device aims to facilitate early detection of metabolic dysfunction and personalized management of conditions like prediabetes and type 2 diabetes.
Target Audience
The primary target audience includes individuals at risk of or diagnosed with prediabetes or type 2 diabetes, as well as healthcare professionals seeking a convenient tool for metabolic assessment.
Features
- Non-invasive measurement of insulin resistance through a handheld biosensor
- Real-time feedback on metabolic health status
- Portable design for convenient use at home or on the go
- Data tracking and analysis to monitor trends and progress